News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Mulligan Seamus
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/15/2023 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 3,075 shares
@ $0 |
|
06/12/2023 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Exercised 4,500 options to buy
@ $81.76, valued at
$367.9k
|
|
03/07/2023 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Exercised 4,500 options to buy
@ $59.13, valued at
$266.1k
|
|
08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2021 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 2,246 shares
@ $0 |
|
08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2020 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Bought 15,000 shares
@ $110.6498, valued at
$1.7M
Bought 5,243 shares
@ $109.5516, valued at
$574.4k
Bought 8,391 shares
@ $110.5174, valued at
$927.4k
Bought 9,884 shares
@ $111.5623, valued at
$1.1M
Bought 11,482 shares
@ $112.3189, valued at
$1.3M
|
|
08/12/2019 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 1,920 shares
@ $0 Granted 4,805 options to buy
@ $137.12, valued at
$658.9k
|
|
03/21/2019 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns:
| Granted 7,569 shares
@ $0 |
|
03/21/2019 |
3
| Mulligan Seamus (Director) has filed a Form 3 on Emergent BioSolutions Inc. |
11/19/2018 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Bought 300 shares
@ $141.8633, valued at
$42.6k
Bought 1,200 shares
@ $143.2242, valued at
$171.9k
Bought 26,363 shares
@ $144.2431, valued at
$3.8M
Bought 22,137 shares
@ $145.0464, valued at
$3.2M
|
|
08/13/2018 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 1,495 shares
@ $0 Granted 3,735 options to buy
@ $177.73, valued at
$663.8k
|
|
08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/26/2016 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Sold 3,565 shares
@ $126.651, valued at
$451.5k
Sold 9,500 shares
@ $127.7028, valued at
$1.2M
Sold 10,283 shares
@ $128.9693, valued at
$1.3M
Sold 4,620 shares
@ $129.4174, valued at
$597.9k
|
|
08/15/2016 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 1,365 shares
@ $0 Granted 3,415 options to buy
@ $138.08, valued at
$471.5k
|
|
05/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/12/2013 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 2,250 shares
@ $0 Granted 4,500 options to buy
@ $81.76, valued at
$367.9k
|
|
03/06/2013 |
4/A
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 2,250 shares
@ $0 Sold 425,000 shares
@ $58.28, valued at
$24.8M
Granted 4,500 options to buy
@ $59.13, valued at
$266.1k
|
|
03/06/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/13/2012 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Granted 17,500 shares
@ $0 Granted 35,000 options to buy
@ $46.83, valued at
$1.6M
|
|
03/13/2012 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns:
| Sold 2,000,000 shares
@ $49.56, valued at
$99.1M
Gifted 864,954 shares
@ $0 Gifted 864,954 shares
@ $0 |
|
01/18/2012 |
3
| Mulligan Seamus (See Remarks) has filed a Form 3 on Jazz Pharmaceuticals plc |
|
|